Therefore, the overexpression of SLC7A11 in ovarian cancer cells enhances GPX4 activity by increasing GSH levels, which assists cells in resisting ferroptosis and promotes cancer cell proliferation, invasion, and chemoresistance (Fantone et al., 2024). Here, SLC7A11 is linked to ovarian cancer.